BROMLEY COMMON PRACTICE — All Prescriptions & Medications
Practice Code: G84024 | BROMLEY, BR2 9GT
Over the last 12 months, BROMLEY COMMON PRACTICE prescribed 104,209 items across 514 different medications at a total cost of £1,255,342 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Desloratadine | 10 | 780 | £58 | -65.3% ▼ |
| Sodium chloride | 10 | 1,700 | £175 | -57.7% ▼ |
| Powder 2 kcal/ml m/sk higher volume, higher energy (0913011) | 10 | 486 | £1.7K | +0.7% vs avg |
| RtS 2 - 2.4 kcal/ml m/sk lower volume with fibre (0913011) | 10 | 35.0K | £782 | -19.4% ▼ |
| Leflunomide | 10 | 450 | £27 | -73.6% ▼ |
| Erythromycin | 10 | 370 | £161 | -26.4% ▼ |
| 10 | 175 | £153 | +13.8% ▲ | |
| 10 | 182 | £211 | +15.5% ▲ | |
| 10 | 110 | £359 | -67.5% ▼ | |
| 10 | 1,200 | £168 | -74.3% ▼ | |
| Sennosides | 11 | 4,100 | £77 | -64.4% ▼ |
| Olmesartan medoxomil/amlodipine | 11 | 588 | £338 | -16.6% ▼ |
| Domperidone | 11 | 924 | £21 | -69.2% ▼ |
| Water for injection | 11 | 130 | £40 | -67.5% ▼ |
| Nicotinamide | 11 | 616 | £36 | +19.9% ▲ |
| Celecoxib | 11 | 660 | £27 | -83.3% ▼ |
| Betamethasone sodium phosphate | 11 | 120 | £27 | -57.5% ▼ |
| Light liquid paraffin | 11 | 11.0K | £202 | -67.7% ▼ |
| 11 | 310 | £293 | -40.0% ▼ | |
| 11 | 220 | £2.8K | +5.2% ▲ | |
| 11 | 11 | £207 | +28.1% ▲ | |
| 11 | 330 | £182 | +6.5% ▲ | |
| Magnesium hydroxide | 12 | 14.4K | £287 | +79.4% ▲ |
| Tibolone | 12 | 336 | £31 | -60.8% ▼ |
| Dienogest | 12 | 728 | £507 | +65.7% ▲ |
| Powder amino acid formula (0913131) | 12 | 40.0K | £3.9K | +12.5% ▲ |
| Tube feed 1 kcal/ml peptide based (0914041) | 12 | 402.5K | £13.1K | +35.0% ▲ |
| Ciclosporin (Eye Anti Inflammatory) | 12 | 450 | £1.1K | -51.6% ▼ |
| Ciprofloxain/dexameth | 12 | 60 | £70 | -60.9% ▼ |
| Mupirocin | 12 | 69 | £93 | +2.2% ▲ |
| Menthol | 12 | 3,600 | £135 | -57.4% ▼ |
| Crotamiton | 12 | 1,580 | £97 | -27.8% ▼ |
| Pimecrolimus | 12 | 360 | £225 | -29.1% ▼ |
| 12 | 340 | £179 | -69.6% ▼ | |
| 12 | 130 | £114 | -61.5% ▼ | |
| 12 | 115 | £59 | -58.6% ▼ | |
| 12 | 13 | £1.6K | +37.8% ▲ | |
| 12 | 589 | £176 | -85.1% ▼ | |
| 12 | 810 | £1.8K | -15.2% ▼ | |
| Amiloride hydrochloride | 13 | 616 | £311 | -48.4% ▼ |
| Hydralazine hydrochloride | 13 | 1,148 | £58 | -69.2% ▼ |
| INR blood testing reagents | 13 | 408 | £1.1K | +72.5% ▲ |
| Orlistat | 13 | 1,512 | £366 | -84.2% ▼ |
| Erythromycin | 13 | 568 | £184 | -62.5% ▼ |
| Testosterone undecanoate | 13 | 13 | £1.1K | -48.8% ▼ |
| Phentolamine/aviptadil | 13 | 64 | £608 | +82.1% ▲ |
| Vitamin A | 13 | 1,092 | £104 | +15.3% ▲ |
| Vitamin E | 13 | 390 | £13 | +19.6% ▲ |
| Menadiol sodium phosphate | 13 | 390 | £946 | +129.4% ▲ |
| Other compound vitamin/mineral formulation preparations | 13 | 390 | £39 | -59.5% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.